| pubmed-article:17290194 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17290194 | lifeskim:mentions | umls-concept:C0035328 | lld:lifeskim |
| pubmed-article:17290194 | lifeskim:mentions | umls-concept:C0796392 | lld:lifeskim |
| pubmed-article:17290194 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:17290194 | lifeskim:mentions | umls-concept:C0205099 | lld:lifeskim |
| pubmed-article:17290194 | lifeskim:mentions | umls-concept:C1517572 | lld:lifeskim |
| pubmed-article:17290194 | lifeskim:mentions | umls-concept:C1656863 | lld:lifeskim |
| pubmed-article:17290194 | lifeskim:mentions | umls-concept:C1135130 | lld:lifeskim |
| pubmed-article:17290194 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:17290194 | pubmed:dateCreated | 2007-2-9 | lld:pubmed |
| pubmed-article:17290194 | pubmed:abstractText | To evaluate the safety, visual acuity changes, and morphologic effects associated with intravitreal bevacizumab injections for the management of macular edema due to ischemic central or hemicentral retinal vein occlusion (RVO). | lld:pubmed |
| pubmed-article:17290194 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17290194 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17290194 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17290194 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17290194 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17290194 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17290194 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17290194 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17290194 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17290194 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17290194 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:17290194 | pubmed:issn | 0275-004X | lld:pubmed |
| pubmed-article:17290194 | pubmed:author | pubmed-author:ScottIngrid... | lld:pubmed |
| pubmed-article:17290194 | pubmed:author | pubmed-author:JorgeRodrigoR | lld:pubmed |
| pubmed-article:17290194 | pubmed:author | pubmed-author:CardilloJosé... | lld:pubmed |
| pubmed-article:17290194 | pubmed:author | pubmed-author:CostaRogério... | lld:pubmed |
| pubmed-article:17290194 | pubmed:author | pubmed-author:CalucciDaniel... | lld:pubmed |
| pubmed-article:17290194 | pubmed:author | pubmed-author:MeloLuiz... | lld:pubmed |
| pubmed-article:17290194 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17290194 | pubmed:volume | 27 | lld:pubmed |
| pubmed-article:17290194 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17290194 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17290194 | pubmed:pagination | 141-9 | lld:pubmed |
| pubmed-article:17290194 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:17290194 | pubmed:meshHeading | pubmed-meshheading:17290194... | lld:pubmed |
| pubmed-article:17290194 | pubmed:meshHeading | pubmed-meshheading:17290194... | lld:pubmed |
| pubmed-article:17290194 | pubmed:meshHeading | pubmed-meshheading:17290194... | lld:pubmed |
| pubmed-article:17290194 | pubmed:meshHeading | pubmed-meshheading:17290194... | lld:pubmed |
| pubmed-article:17290194 | pubmed:meshHeading | pubmed-meshheading:17290194... | lld:pubmed |
| pubmed-article:17290194 | pubmed:meshHeading | pubmed-meshheading:17290194... | lld:pubmed |
| pubmed-article:17290194 | pubmed:meshHeading | pubmed-meshheading:17290194... | lld:pubmed |
| pubmed-article:17290194 | pubmed:meshHeading | pubmed-meshheading:17290194... | lld:pubmed |
| pubmed-article:17290194 | pubmed:meshHeading | pubmed-meshheading:17290194... | lld:pubmed |
| pubmed-article:17290194 | pubmed:meshHeading | pubmed-meshheading:17290194... | lld:pubmed |
| pubmed-article:17290194 | pubmed:meshHeading | pubmed-meshheading:17290194... | lld:pubmed |
| pubmed-article:17290194 | pubmed:meshHeading | pubmed-meshheading:17290194... | lld:pubmed |
| pubmed-article:17290194 | pubmed:meshHeading | pubmed-meshheading:17290194... | lld:pubmed |
| pubmed-article:17290194 | pubmed:meshHeading | pubmed-meshheading:17290194... | lld:pubmed |
| pubmed-article:17290194 | pubmed:meshHeading | pubmed-meshheading:17290194... | lld:pubmed |
| pubmed-article:17290194 | pubmed:meshHeading | pubmed-meshheading:17290194... | lld:pubmed |
| pubmed-article:17290194 | pubmed:meshHeading | pubmed-meshheading:17290194... | lld:pubmed |
| pubmed-article:17290194 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17290194 | pubmed:articleTitle | Intravitreal bevacizumab (avastin) for central and hemicentral retinal vein occlusions: IBeVO study. | lld:pubmed |
| pubmed-article:17290194 | pubmed:affiliation | U.D.A.T.--Macular Imaging aaaa Treatment Division, Hospital de Olhos de Araraquara, Araraquara, São Paulo, Brazil. roger.retina@globo.com | lld:pubmed |
| pubmed-article:17290194 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17290194 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17290194 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17290194 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17290194 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17290194 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17290194 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17290194 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17290194 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17290194 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17290194 | lld:pubmed |
